|
XERS Xeris Biopharma Holdings Inc 1867096 |
| Balance Sheet |
|
Current Assets
|
162,799,000 |
|
Assets
|
321,104,000 |
|
Current Liabilities
|
91,013,000 |
|
Liabilities
|
349,427,000 |
|
Equity
|
-28,323,000 |
|
Shares Out
|
148,999,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-38,956,000 |
|
Investing Cash Flow
|
-5,133,000 |
| Market Analysis |
Market Cap
|
452,956,346 |
|
Price
|
3.20 |
|
BVPS
|
3.79 |
|
PB
|
0.84 |
|
EPS
|
-0.42 |
|
PS
|
2.09 |
|
FCF
|
-44,089,000 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view XERS documents filed with the SEC.
XERS Filings
Clear
